VOYA Investment Management’s ADMA Biologics ADMA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.5M | Buy |
1,398,906
+524,303
| +60% | +$9.55M | 0.03% | 463 |
|
2025
Q1 | $17.4M | Sell |
874,603
-43,758
| -5% | -$868K | 0.02% | 568 |
|
2024
Q4 | $15.7M | Buy |
918,361
+292,642
| +47% | +$5.02M | 0.02% | 617 |
|
2024
Q3 | $12.5M | Buy |
625,719
+83,477
| +15% | +$1.67M | 0.01% | 697 |
|
2024
Q2 | $6.06M | Buy |
542,242
+471,080
| +662% | +$5.27M | 0.01% | 910 |
|
2024
Q1 | $470K | Sell |
71,162
-15,333
| -18% | -$101K | ﹤0.01% | 2043 |
|
2023
Q4 | $391K | Buy |
86,495
+1,056
| +1% | +$4.77K | ﹤0.01% | 2203 |
|
2023
Q3 | $306K | Buy |
85,439
+1,474
| +2% | +$5.28K | ﹤0.01% | 2297 |
|
2023
Q2 | $310K | Buy |
83,965
+12,652
| +18% | +$46.7K | ﹤0.01% | 2346 |
|
2023
Q1 | $236K | Hold |
71,313
| – | – | ﹤0.01% | 2442 |
|
2022
Q4 | $277K | Hold |
71,313
| – | – | ﹤0.01% | 2384 |
|
2022
Q3 | $173K | Hold |
71,313
| – | – | ﹤0.01% | 2647 |
|
2022
Q2 | $141K | Buy |
+71,313
| New | +$141K | ﹤0.01% | 2528 |
|
2021
Q2 | – | Sell |
-29,207
| Closed | -$51K | – | 2803 |
|
2021
Q1 | $51K | Hold |
29,207
| – | – | ﹤0.01% | 2743 |
|
2020
Q4 | $57K | Buy |
29,207
+4,894
| +20% | +$9.55K | ﹤0.01% | 2644 |
|
2020
Q3 | $58K | Hold |
24,313
| – | – | ﹤0.01% | 2418 |
|
2020
Q2 | $71K | Sell |
24,313
-9,523
| -28% | -$27.8K | ﹤0.01% | 2388 |
|
2020
Q1 | $97K | Buy |
33,836
+7,807
| +30% | +$22.4K | ﹤0.01% | 2352 |
|
2019
Q4 | $104K | Buy |
26,029
+7,341
| +39% | +$29.3K | ﹤0.01% | 2537 |
|
2019
Q3 | $83K | Buy |
18,688
+7,038
| +60% | +$31.3K | ﹤0.01% | 2440 |
|
2019
Q2 | $45K | Buy |
+11,650
| New | +$45K | ﹤0.01% | 2568 |
|